Kava: a test case for Canada's new approach to natural health products

Boon, Heather S.; Wong, Albert H.C.
November 2003
CMAJ: Canadian Medical Association Journal;11/25/2003, Vol. 169 Issue 11, p1163
Academic Journal
Comments on the use of the herbal kava for treating anxiety. Recommended dose of kava extract; Criticisms of the evidence for kava hepatotoxicity; Significance of the 2002 decision of Health Canada to reclassify kava as a conventional drug.


Related Articles

  • Kava: Safe Serenity or Dangerous Dope? Stoppani, Jim // Joe Weider's Muscle & Fitness;Jul2003, Vol. 64 Issue 7, p52 

    Addresses the safety issue surrounding kava or piper methyscticum, a herb that promotes relaxation and used in treating anxiety. Key ingredients of kava; Reason for the kava ban in Canada, Australia and other European countries; Number of suspected deaths and liver disease associated with kava...

  • In Vitro Toxicity of Kava Alkaloid, Pipermethystine, in HepG2 Cells Compared to Kavalactones. Nerurkar, Pratibha V.; Dragull, Klaus; Chung-Shih Tang // Toxicological Sciences;May2004, Vol. 79 Issue 1, p106 

    Kava herbal supplements have been recently associated with acute hepatotoxicity, leading to the ban of kava products in approximately a dozen countries around the world. It is suspected that some alkaloids from aerial kava may have contributed to the problem. Traditionally, Pacific Islanders use...

  • Kava: A Polynesian gift for anxiety, tension, and insomnia. Dolby, Victoria // Better Nutrition;Jun96, Vol. 58 Issue 6, p26 

    Presents information on therapeutic South Pacific herb called kava. Discovery by Captain James Cook; Ability to induce mental relaxation and feelings of well-being; Side effects; Results of clinical trial comparing kava with a placebo in patients with anxiety syndrome; Precautions.

  • Natural tranquilizers? Cerrato, Paul L. // RN;Dec98, Vol. 61 Issue 12, p61 

    Reviews the possible benefits and adverse effects of herbal therapies, kava and valerian. Anxiety-relieving effects of kava; Use of valerian as mild tranquilizer and sleeping aid for hundred years; Discovery of compounds in valerian that cause central nervous system depression and muscle...

  • Kava: a safe soother. Cohen, Sharon // Shape;Jan2001, Vol. 20 Issue 5, p33 

    Reports on the finding that doses of kava for up to 300 milligrams a day are effective and safe for treating anxiety.

  • NY TIMES QUESTIONS HERBS.  // American Herb Association Quarterly Newsletter;Summer2003, Vol. 19 Issue 1, p7 

    Reports on the potential adverse effects of herbal medicine. Effect of kava plant and aristolochia on urothelial cancer; Effect of valerian on insomia and echinacea.

  • Research Reviews. Assessment of Clinical Data on Hepatotoxicity Associated with Kava Use. Oliff, Heather S. // HerbalGram;Feb-Apr2011, Issue 89, p30 

    The article reviews the article “Kava Hepatotoxicity. A Clinical Review, by R. Teschke in a 2010 issue of "Ann Hepatol."

  • Kava safety questioned due to case reports of liver toxicity. Blumenthal, Mark // HerbalGram;Summer2002, Issue 55, p26 

    Examines the potential hepatotoxicity of kava plant. Background of kava; Evaluation of kava adverse event reports; Cases of liver toxicity associated with kava; Kava safety and precautions.

  • Are Kavalactones the Hepatotoxic Principle of Kava Extracts? The Pitfalls of the Glutathione Theory. Schmidt, Mathias // Journal of Alternative & Complementary Medicine;Apr2003, Vol. 9 Issue 2, p183 

    Comments on a study on the hepatotoxicity of kava extracts. Background of toxicologic studies with kava extract and isolated kavalactones; Details on kavalactone-free preparations; Information on the acute toxicity of kavalactones in animal experiments.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics